Staphylococcal pyoderma: An emerging problem

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 26, Issue 7, 2004, Pages 560-568

  Hnilica, Keith A ^a   May, Elizabeth ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INTERMEDIUS; STAPHYLOCOCCUS SCHLEIFERI;

EID: 4043067201     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Crossley KB, Archer GL (eds): The Staphylococci in Human Disease. New York, Churchill Livingston, 1997.
2. Scott DW, Miller WH, Griffin CE (eds): Muller and Kirk's Small Animal Dermatology, ed 6. Philadelphia, WB Saunders, 2001.
3. Manian FA: Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 36:e26-e28, 2003.
4. Frank LA, Kania SA, Hnilica KA, et al: Isolation of Staphylococcus schleiferi from dogs with pyoaderma. JAVMA 15:222(4):451-454, 2003.
5. Igimi S, Takahashi E, Mitsuoka T: Staphylococcus schleiferi subsp coagulans subsp Nov, isolated from the external auditory meatus of dogs with external ear otitis. Int J Syst Bacteriol 40(4):409-411, 1990.
6. Guerin-Faublee MB, Freney J, Etienne J: Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma. Vet Rec 150:487-488, 2001.
7. Tanner MA, Everett CL, Youvan DC: Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J Clin Microbiol 38(4):1628-1631, 2000.
8. Talan DA, Staatz D, Staatz A, Overturf GD: Frequency of Staphylococcus intermedius as human nasopharyngeal flora. J Clin Microbiol 27(10):2393, 1989.
9. Hernandez JL, Calvo J, Sota R, et al: Clinical and microbiological characteristics of 28 patients with Staphylococcus schleiferi infection. Eur J Clin Microbiol Infect Dis 20:153-158, 2001.
10. Hájek V: Staphylococcus intermedius, a new species isolated from animals. Int J Syst Bocteriol 26(4):401-408, 1976.
11. Igimi S, Atobe H, Tohya Y, et al: Characterization of the most frequently encountered Staphylococcus sp in cats. Vet Microbiol 39:255-260, 1994.
12. McEwan NA: Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis. Res Vet Sci 68:279-283, 2000.
13. Hendricks A, Schuberth H-J, Schueler K, Lloyd DH: Frequency of superantigen-producing Staphylococcus intermedius isolates from canine pyoderma and proliferation-inducing potential of superantigens in dogs. Vet Sci 73:273-277, 2002.
14. Prescott JF, Hanna WJ, Reid-Smith R, Drost K: Antimicrobial drug use and resistance in dogs. Can Vet J 43(2):107-116, 2002.
15. Noble WC, Kent LE: Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Vet Dermatol 3(20):71-74, 1992.
16. Gortel K, Campbell KL, Kakoma I, et al: Methicillin resistance among staphylococci isolated form dogs. Am J Vet Res 60(12):1526-1530, 1999.
17. Paradis M, Lemay S, Scott DW, et al: Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet Dermatol 1:123-127, 1990.
18. Barber M: Methicillin-resistant staphylococci. J Clin Pathol 14:385-393, 1961.
19. Peters G, Becker K: Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 52(suppl 2):51-54, 1996.
20. Freney J, Brun Y, Bes M, et al: Staphylococcus lugdunensis. sp Nov and Staphylococcus schleiferi sp Nov, two species from human clinical specimens. Int J Syst Bacteriol 38(2):168-172, 1988.
21. Jean-Pierre H, Darbas H, Jean-Roussenq A, Boyer G: Pathogenicity in two cases of Staphylococcus schleiferi, a recently described species. J Clin Microbiol 27(9):2110-2111, 1989.
22. Calvo J, Hernandez JL, Farinas MC, et al: Osteomyelitis caused by Staphylococcus schleiferi and evidence of misidentification of the Staphylococcus species by an automated bacterial identification system. J Clin Microbiol 38(10):3887-3889, 2000.
23. Celard M, Vandenesch F, Darbas H, et al: Pacemaker infection caused by Staphylococcus schleiferi, a member of the human preaxillary flora: Four case reports. Clin Infect Dis 24:1014-1015, 1997.
24. Vandenesch F, Lebeau C, Ges M, et al: Clotting activity in Staphylococcus schleiferi subspecies from human patients J Clin Microbiol 32(2):388-392, 1994.
25. Romanenko EE, Baturo AP, Mokronosova MA, et al: Microflora of the nasal mucosa in allergic annual and infectious rhinitis. Zh Mikrobiol Epidemiol Immunoboil 66-71, 2003.
26. Ozturkeri H, Kocabeyoglu O, Yergok YZ, et al: Distribution of coagulase-negative staphylococci, including the newly described species Staphylococcus schleiferi, in nosocomial and community acquired urinary tract infections. Eur J Clin Microbiol Infect Dis 13:1076-1079, 1994.
27. Costa AD, Lelievre H, Kirkorian G, et al: Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 97(18):1791-1795, 1998.
28. Kania S, Williamson N, Frank LA, et al: Unpublished data, mecA expression in Staphylococcus schleiferi, The University of Tennessee, Knoxville, 2003.
29. May E, Hnilica KA, Frank LA, et al: Unpublished data, Evaluation of the frequency and significance of Staphylococcus schleiferi in canine ear disease, The University of Tennessee, Knoxville, 2003.
30. Ganiere J, Medaille C, Limet A, et al: Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet Dermatol 12:171-175, 2001.
31. Lloyd DH, Lamport AI, Noble WC, Howell SA: Fluoroquinolone resistance: Staphylococcus intermedius. Vet Dermatol 10:249-251, 1999.
32. Neu HC: Bacterial resistance to fluoroquinolones. Rev Infect Dis 10(1):S57-S63, 1988.